Mehmet Zincirci

Dr. Mehmet Zincirci

orcid

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 June 2021 in European Archives of Medical Research
Verified
Journal Article
Closed access
CKCansu Berktaş Kılınç
Cansu Berktaş Kılınç
MZMehmet Zincirci
Mehmet Zincirci
IGİbRahim Gün
İbRahim Gün
NTNamigar Turgut
Namigar Turgut
SKSerap Karacalar
Serap Karacalar
NBNihan Altintepe Baskurt
Nihan Altintepe Baskurt

1 July 2026 in Ağrı - The Journal of The Turkish Society of Algology
Verified
Journal Article
Open access
PDF file
DZDilara Ekici Zincirci
Dilara Ekici Zincirci
BÖBerkin Özer
Berkin Özer
SASevgi Atar
Sevgi Atar
EDESMA DEMIRHAN
ESMA DEMIRHAN
MZMehmet Zincirci
Mehmet Zincirci
ÖKÖmer Kuru
Ömer Kuru
Background: This study aimed to evaluate whether the magnesium depletion score (MDS), an indicator of magnesium deficiency, is associated with the development of complex regional pain syndrome type 1 (CRPS-1) in patients with traumatic extremity injuries. Patients and Methods: Between November 2024 and May 2025, a total of 117 patients who suffered from traumatic extremity injuries were included. Demographic and clinical data of the patients were collected and recorded, and the MDS was calculated. Age, sex, body mass index (BMI), smoking status, alcohol consumption, diabetes, hypertension, duration of immobilization, MDS, and injury-related characteristics were evaluated as potential risk factors for CRPS-1 development. Results: Of the patients, 40 were male and 77 were female with a mean age of 51.9 ± 15.01 (range, 20 to 91 years). In a total of 42.7% of patients with traumatic extremity injuries, CRPS-1 developed. The female-to-male ratio was higher among patients with CRPS-1 than among those without. The MDS, hypertension, diabetes, smoking, and alcohol consumption were not found to be independent risk factors. However, prolonged immobilization (more than one month) was found to be an independent risk factor for the development of CRPS-1. Conclusion: Our study results suggest that the MDS score is not a risk factor for developing CRPS-1, but immobilization for more than one month significantly increases the risk. Taken together, these findings indicate that the duration of immobilization following injury may be a more decisive factor in the development of CRPS-1 than demographic and clinical characteristics.

15 July 2026 in Indian Journal of Orthopaedics
Verified
Journal Article
Closed access
DZDilara Ekici Zincirci
Dilara Ekici Zincirci
SASevgi Atar
Sevgi Atar
EDESMA DEMIRHAN
ESMA DEMIRHAN
MZMehmet Zincirci
Mehmet Zincirci
DFDemet Ferahman
Demet Ferahman
ÖKÖmer Kuru
Ömer Kuru

13 April 2026 in Medicina
Verified
Journal Article
Open access
PDF file
DZDilara Ekici Zincirci
Dilara Ekici Zincirci
IYİrem Nur Yılmaz
İrem Nur Yılmaz
SASevgi Atar
Sevgi Atar
EDESMA DEMIRHAN
ESMA DEMIRHAN
IEİmran Arkan Emre
İmran Arkan Emre
ÖKÖmer Kuru
Ömer Kuru
Background and Objectives: Fibromyalgia syndrome (FMS) is frequently accompanied by autonomic symptoms and autonomic dysregulation, which may influence ocular blood flow regulation. The choroid is a densely vascular, autonomically innervated tissue, and optical coherence tomography (OCT)-derived markers have been used to explore potential ocular microvascular changes in FMS, with inconsistent findings. The choroidal vascularity index (CVI), defined as the proportion of luminal area within the total choroidal area, has been proposed as a potentially more robust marker of choroidal vascular status than thickness alone. We aimed to compare CVI and choroidal thickness between patients with FMS and healthy controls and examine the association between autonomic symptom burden and CVI in FMS. Materials and Methods: This single-centre observational cross-sectional case–control study enrolled adults aged 18–65 years. Swept-source OCT was performed; low-quality scans were excluded, and only right eyes were analysed. CVI, subfoveal maximum and mean choroidal thickness were obtained using an artificial intelligence-assisted analysis platform. Autonomic symptom burden, fibromyalgia impact, and central sensitization-related symptoms were assessed using the Composite Autonomic Symptom Score-31 (COMPASS-31), the Revised Fibromyalgia Impact Questionnaire (FIQ-R), and the Central Sensitization Inventory (CSI), respectively. Group comparisons, Spearman correlations, and multivariable linear regression were performed. Results: COMPASS-31, FIQ-R, and CSI scores were higher in the FMS group (all p < 0.001). CVI and choroidal thickness did not differ significantly between groups (CVI p = 0.124; maximum thickness p = 0.136; mean thickness p = 0.097). CVI was not correlated with COMPASS-31, FIQ-R, or CSI within either group. In adjusted models, age was independently associated with CVI (p < 0.001), whereas FMS status and COMPASS-31 total score were not. Conclusions: CVI and choroidal thickness were similar in FMS and controls, and CVI was not associated with self-reported autonomic symptom burden in FMS. Studies incorporating objective autonomic testing and dynamic vascular imaging paradigms are warranted.